Chemical Structure For Cilostazol (Image 1)
Cilostazol Tablet
Product Images NDC 63629-8795
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 63629-8795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Image 2)
This is a chart that displays the plasma concentration in ng/mL of three chemicals: cilostazol, 3,4-dehydrocilostazol, and 4'-trans-hydroxycilostazol over an unspecified period of time (represented on the x-axis in hours).*
Figure 2 (Image 3)
This is a chart that shows the percent mean improvement in maximal walking distance for different drugs and a placebo. The drugs included are Cilostazol 50 mg b.i.d and Cilostazol 100 mg b.i.d. The chart also indicates the number of participants for each drug and the duration of the study.*
Label (Lbl636298795)
This is a medication called NILD, with a VSN number of 0516. Each tablet contains 100mg of cilostazol, USP. The usual dosage is 1 tablet twice daily. It should be kept out of the reach of children and stored at 20°C to 25°C. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure. The NDC number for this medication is 63629-8795-1 and it is available in a box with 60 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
